Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00061828 · ClinicalTrials.gov registry record
A Prospective Database of Infants With Cholestasis
A clinical trial of Biliary Atresia, sponsored by Arbor Research Collaborative for Health.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 16
- Study locations
NCT00061828 is a study of Biliary Atresia that is actively recruiting participants, run by Arbor Research Collaborative for Health. The registered enrollment target is 1,000 participants, above the 432-participant average among 7 other Biliary Atresia trials with a reported enrollment target (131% higher). The trial reports 16 study locations across 14 states.
The verdict
NCT00061828, a study of Biliary Atresia, is actively recruiting participants, sponsored by Arbor Research Collaborative for Health.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 16
- Study locations
Study Summary
Biliary atresia, idiopathic neonatal hepatitis, and specific genetic cholestatic conditions are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Childhood Liver Disease Research Network (ChiLDReN) is to establish a database of clinical information and plasma, serum, and tissue samples from cholestatic children to facilitate research and to perform clinical, epidemiological and therapeutic trials in these important pediatric liver diseases.
Conditions Studied
Study Locations (16)
California
- Children's Hospital Los Angeles - Los Angeles
- University of California - San Francisco
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
- UPMC Children's Hospital of Pittsburgh - Pittsburgh
Colorado
- Children's Hospital Colorado - Aurora
Georgia
- Children's Healthcare of Atlanta - Emory University - Atlanta
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
Indiana
- Riley Hospital for Children - Indianapolis
Maryland
- Johns Hopkins School of Medicine - Baltimore
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2004-04-21 |
| Est. Completion | 2029-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00061828
The ClinicalTrials.gov registry entry for NCT00061828 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 432-participant average among 7 other Biliary Atresia trials with a reported enrollment target (131% higher). The listed sponsor is Arbor Research Collaborative for Health, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Biliary Atresia appearing as the primary indexed condition, and to 0 interventions.
NCT00061828 reports 16 study locations spanning 14 distinct geographic areas - top geographies include California, Pennsylvania, Colorado.
Frequently Asked Questions
What is clinical trial NCT00061828 about?
NCT00061828 is a clinical study titled "A Prospective Database of Infants With Cholestasis". Biliary atresia, idiopathic neonatal hepatitis, and specific genetic cholestatic conditions are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Childhood Liver Disease Research Network (ChiLDReN) is to establish a database ...
What is the current status of trial NCT00061828?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2004-04-21. Estimated completion is 2029-05-31.
What conditions does trial NCT00061828 study?
This clinical trial studies the following conditions: Biliary Atresia.
Who is sponsoring clinical trial NCT00061828?
This trial is sponsored by Arbor Research Collaborative for Health, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00061828 being conducted?
This trial has 16 study locations across California, Colorado, Georgia, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Biliary Atresia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mapping Disease Pathways for Biliary Atresia
RECRUITING
-
Biliary Atresia Research Network Northeast
RECRUITING
-
Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
RECRUITING · Phase 1
-
Biliary Atresia Study in Infants and Children
RECRUITING
-
The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis
RECRUITING · Early Phase 1
-
Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.